HDGFL2 and malaria: This is particularly true for malaria, where molecular surveillance is a standard approach to monitor pathogen variants, which are associated with drug resistance, or jeopardize reliable diagnostics (e.g., P. falciparum variants with deletions in the HRP2/3 genes, which can lead to false-negative rapid diagnostic test results [cf. (52)].